New York, New York--(Newsfile Corp. - January 14, 2026) - OS Therapies Inc. ("OS Therapies" or "the Company"), the world leader in listeria-based cancer immunotherapies, today announced that its ...
OS Animal Health (OSAH), a wholly owned OS Therapies (OSTX) subsidiary, targets an IPO on NYSE American or Nasdaq Capital Markets in the first half of 2026. OS Therapies Inc. (NYSE:OSTX) Two (2) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results